New York, Jan 12, 2026, 14:15 EST — Regular session
- Shares tick higher in afternoon trading after Goldman Sachs kicks off coverage with a Buy rating and $330 price target
- Goldman highlights “AI adoption” as a key demand driver; investors await clearer signs of Agentforce revenue growth
- Salesforce will present at the J.P. Morgan Healthcare Conference on Jan. 13
Salesforce shares nudged higher Monday after Goldman Sachs analyst Gabriela Borges initiated coverage with a Buy rating and set a $330 price target. Borges highlighted AI adoption as a “positive tailwind” for software demand. The stock climbed 0.3% to $260.76 in mid-afternoon trading in New York. 1
The call comes as investors seek solid proof that Salesforce can convert Agentforce—its AI-driven task automation initiative—into accelerated subscription growth, rather than just generating demos and pilots.
A major Wall Street bank’s fresh coverage can move a stock like Salesforce, given the crowded positioning where even slight shifts in sentiment can trigger flows. This update comes just before the company’s appearance at a key investor conference this week.
Goldman, in a note flagged by Investing.com, estimates Agentforce could boost Salesforce’s “Platform and Other” revenue by about 4% over the next 12 to 18 months, potentially sparking a revenue inflection as soon as 2026. However, the bank also warns that gains might be partly offset by continued share declines in Commerce and Marketing Cloud. 2
The broader market held steady as the S&P 500-linked SPY ETF gained roughly 0.2%, with the tech-focused QQQ matching that rise. ServiceNow edged up 0.8%, while Oracle jumped 3.3%.
Salesforce is pushing growth by doubling down on AI and data tools. In its December quarter, the company boosted its full-year revenue forecast to between $41.45 billion and $41.55 billion. Meanwhile, Agentforce and Data 360 annual recurring revenue — a key subscription metric — hit nearly $1.4 billion, soaring 114% from the previous year. 3
The next key event is Tuesday, when Salesforce President of Sales Mark Sullivan will speak at the J.P. Morgan Healthcare Conference at 2:15 p.m. PT, per the company’s events calendar. 4
Salesforce hasn’t set a date for its upcoming earnings release yet, though Nasdaq’s earnings calendar pegs it around Feb. 25. That report usually offers a key look at whether new products are beginning to boost billings and guidance. 5
The AI trade can shift fast. If customers drag their feet moving from trials to full rollouts — or if competitors snag deals through better pricing or integration — revenue growth might fall short, despite optimistic research notes.
Monday’s shift was modest. Attention now turns to Tuesday’s conference remarks for signals on demand in a crucial industry segment, followed by the upcoming earnings report later this quarter to gauge 2026 momentum more clearly.
